Can-Fite BioPharma Ltd. (TLV:CANF)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1.300
0.00 (0.00%)
May 29, 2025, 5:24 PM IDT

Can-Fite BioPharma Ratios and Metrics

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
5057326912092
Market Cap Growth
77.98%77.98%-53.52%-42.86%29.93%106.23%
Enterprise Value
22392307657
Last Close Price
0.010.020.030.080.150.20
PS Ratio
20.4223.0911.9024.0645.2037.63
PB Ratio
2.532.861.424.362.684.73
P/TBV Ratio
2.532.861.424.362.684.73
EV/Sales Ratio
8.8715.930.6510.6328.7023.35
Debt / Equity Ratio
0.020.020.010.010.010.01
Asset Turnover
0.070.070.080.060.060.09
Quick Ratio
3.843.844.423.197.016.57
Current Ratio
4.384.384.913.667.357.41
Return on Equity (ROE)
-134.94%-134.94%-142.49%-107.91%-123.34%-339.20%
Return on Assets (ROA)
-53.18%-53.18%-53.15%-42.73%-53.91%-99.87%
Return on Capital (ROIC)
-85.95%-85.95%-94.70%-66.28%-77.75%-204.13%
Earnings Yield
-57.26%-50.64%-86.33%-52.20%-32.72%-50.31%
FCF Yield
-55.53%-49.11%-95.47%-55.47%-25.60%-42.11%
Buyback Yield / Dilution
-70.22%-70.22%-56.71%-47.49%-54.31%-317.19%
Updated Aug 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.